イタリアの体外診断薬市場の規模、シェア、動向分析レポート：製品別（機器、試薬、サービス）、技術別、用途別（感染症、糖尿病、腫瘍/癌）、最終用途別、セグメント別予測、2023年～2030年

Italy In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technology, By Application (Infectious Disease, Diabetes, Oncology/Cancer), By End-use, And Segment Forecasts, 2023 - 2030

イタリアの体外診断用医薬品市場の成長とトレンド Grand View Research, Inc.の最新レポートによると、イタリアの体外診断薬市場規模は、2023年から2030年までCAGR-1.90%で減少し、2030年には37億4000万ドルに... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Grand View Research グランドビューリサーチ	2022年12月20日	US$3,950 シングルユーザライセンス(印刷不可) ライセンス・価格情報注文方法はこちら	120	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

イタリアの体外診断用医薬品市場の成長とトレンド

Grand View Research, Inc.の最新レポートによると、イタリアの体外診断薬市場規模は、2023年から2030年までCAGR-1.90%で減少し、2030年には37億4000万ドルに達すると予測されています。この成長は、対象となる疾患の有病率の増加や、人々の疾患の早期診断に対する意識の高まりにより、IVD製品に対する需要が急増したことに起因しています。さらに、正確で精密、効率的でエラーのない診断を提供するために、さまざまなヘルスケアサービスプロバイダー向けの自動化されたIVDシステムの開発が、今後数年間でイタリアのIVD市場を押し上げると予想されています。

イタリアIVD市場は、柔軟で正確、使いやすく、スピーディな検査を可能にするPOC検査の開発の増加によって支えられると思われます。例えば、2021年4月、DiaSorin社はLIAISON Quick Detect COVID TrimericS Abテストと免疫診断POCリーダーLIAISON IQを発売しました。この検査は、特異的なIgG抗体を10分で検出することができます。また、Menarini Diagnostics s.r.l. が開発した LINX DUO は、HbA1c および CRP 検査のための POC マルチアッセイ自動分析器で、数分間で結果を出すことができます。

また、イタリアIVD市場に参入している企業は、ポイントオブケア検査における製品ポートフォリオを強化するために、提携などの戦略的な取り組みを行っています。例えば、2020年7月、A. Menarini DiagnosticsとSkyla Corporationは、LINX DUOマルチアッセイ分析器およびLINX EVO臨床化学分析器の販売・供給契約を発表しました。この提携により、メナリーニは最先端技術によるPOC診断のポートフォリオを強化することが期待されます。

高齢化社会の到来は、体外診断用医薬品の普及を促進し、その成長を促すと予想されます。Instituto Superiore di Sanitaによると、75歳以上の85％以上の人が慢性疾患に罹患しているとの調査結果が出ています。加齢に伴う主な病気には、心血管障害、関節炎、糖尿病、自己免疫疾患、アルツハイマー病などがあります。慢性疾患の発症リスクの高まりは、この成長をさらに後押しすると期待されています。

さらに、政府機関や主要な市場関係者は、国内の医療サービスを促進するために有利なイニシアティブをとっています。例えば、2022年6月、Sentinel diagnostics社は、糞便免疫化学検査用の高スループットと完全自動化システムであるSENTiFIT 800 Analyzerを発売しました。さらに、2021年4月には、Lumos DiagnosticsとDiaSorinが、ポイントオブケア用ポータブル免疫測定プラットフォーム「LIAISON IQ」の発売に向けて戦略的提携を締結しました。

イタリアの体外診断薬市場レポートハイライト

- 標的疾患の臨床検査需要の増加により、2022年の試薬部門が最大の市場シェアを占める

- 技術別では、技術の継続的な進化と新製品の市場導入により、分子診断分野がイタリアの体外診断（IVD）業界を支配している

- 血液銀行における自動化機器の需要の高まりと輸血の増加により、血液銀行分野が最も速い成長率を示すと予想される

ページTOPに戻る

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3. Italy In Vitro Diagnostics (IVD) Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Growing geriatric population
3.2.1.2 Technological advancements
3.2.1.3 Increasing demand for PoC facilities
3.2.1.4 Growing prevalence of target diseases
3.2.2 Market restraint analysis
3.2.2.1 Higher cost of devices
3.2.2.2 Stringent regulatory and reimbursement policies
3.3 Penetration & Growth Prospect Mapping
3.4 Italy In Vitro Diagnostics (IVD): Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Italy Glucose Strip Market
3.7 Reagents Market by Application and End Use
Chapter 4. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Product, 2018 - 2030 (Revenue, USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Italy In Vitro Diagnostics (IVD) Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Reagents
4.5.2.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Technology 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Technology Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Italy In Vitro Diagnostics (IVD) Market, by Technology, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Immunoassay, by Product
5.5.1.1 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.2 Instruments
5.5.1.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.3 Reagents
5.5.1.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.4 Services
5.5.1.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Immunoassay, by Technology
5.5.2.1 Radioimmunoassay (RIA)
5.5.2.1.1 Radioimmunoassay (RIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2 Enzyme Immunoassays (EIA)/ELISA
5.5.2.2.1 Enzyme Immunoassays (EIA)/ELISA market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2.2 Chemiluminescence Immunoassays (CLIA)
5.5.2.2.2.1 Chemiluminescence Immunoassays (CLIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2.3 Fluorescence Immunoassays (FIA)
5.5.2.2.3.1 Fluorescence Immunoassays (FIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.4 Rapid Test
5.5.2.4.1 Rapid test market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.5 Others
5.5.2.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3 Hematology
5.5.3.1 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.2 Instruments
5.5.3.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.3 Reagents
5.5.3.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.4 Services
5.5.3.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4 Clinical Chemistry
5.5.4.1 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.2 Instruments
5.5.4.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.3 Reagents
5.5.4.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.4 Services
5.5.4.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5 Molecular Diagnostics/Genetics, by Product
5.5.5.1 Molecular diagnostics/genetics market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.2 Instruments
5.5.5.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.3 Reagents
5.5.5.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.4 Services
5.5.5.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6 Molecular Diagnostics/Genetics, by Technology
5.5.6.2 Polymerase Chain Reaction (PCR)
5.5.6.2.1 PCR market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.3 Sequencing
5.5.6.3.1 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.4 Hybridization
5.5.6.4.1 Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.5 Chips & Microarrays
5.5.6.5.1 Chips & microarrays market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.6 TMA
5.5.6.6.1 TMA market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.7 INAAT
5.5.6.7.1 INAAT market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.8 Mass Spectrometry
5.5.6.8.1 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.9 Others
5.5.6.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7 Coagulation
5.5.7.1 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.2 Instruments
5.5.7.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.3 Reagents
5.5.7.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.4 Services
5.5.7.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8 Microbiology
5.5.8.1 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.2 Instruments
5.5.8.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.3 Reagents
5.5.8.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.4 Services
5.5.8.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9 Others
5.5.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.2 Instruments
5.5.9.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.3 Reagents
5.5.9.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.4 Services
5.5.9.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Application, 2018 - 2030 (Revenue, USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Italy In Vitro Diagnostics (IVD) Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Infectious Disease
6.5.1.1 Infectious disease market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Diabetes
6.5.2.1 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3 Oncology/Cancer
6.5.3.1 Oncology/Cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4 Cardiology
6.5.4.1 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5 Nephrology
6.5.5.1 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6 Autoimmune Diseases
6.5.6.1 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7 Drug Testing
6.5.7.1 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
6.5.8 Others
6.5.8.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By End Use, 2018 - 2030 (Revenue, USD Million)
7.1 Definition and Scope
7.2 End Use Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Italy In Vitro Diagnostics (IVD) Market, by End Use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Core Lab
7.5.1.1 Core lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2 SWA, by Location
7.5.1.2.1 SWA market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.2 Public Hospitals
7.5.1.2.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.3 Large Private Hospitals
7.5.1.2.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.4 Private
7.5.1.2.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3 SWA, by Type
7.5.1.3.1 Clinical Chemistry
7.5.1.3.1.1 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.2 Immunochemistry
7.5.1.2.2.1 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3 Hematology
7.5.1.3.1 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.2 Public Hospitals
7.5.1.3.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.3 Large Private Hospitals
7.5.1.3.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.4 Private
7.5.1.3.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4 Coagulation
7.5.1.4.1 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.2 Public Hospitals
7.5.1.4.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.3 Large Private Hospitals
7.5.1.4.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.4 Private
7.5.1.4.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5 Urine Test
7.5.1.5.1 Urine Test market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.2 Public Hospitals
7.5.1.5.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.3 Large Private Hospitals
7.5.1.5.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.4 Private
7.5.1.5.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.6 Others
7.5.1.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Molecular Lab
7.5.2.1 Molecular Lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.2 HPV
7.5.2.2.1 HPV market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.3 Herpetics
7.5.2.3.1 Herpetics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.4 Hepatitis
7.5.2.4.1 Hepatitis market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.5 HIV
7.5.2.5.1 HIV market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.6 NIPT
7.5.2.6.1 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.7 Others
7.5.2.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Pathology Lab
7.5.3.1 Pathology Lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2 Advanced Staining (Immunohistochemistry)
7.5.3.2.1 Advanced staining (Immunohistochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.2 Public Hospitals
7.5.3.2.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.3 Large Private Hospitals
7.5.3.2.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.4 Private
7.5.3.2.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3 Primary Staining (Hematoxylin Eosin and Histochemistry)
7.5.3.3.1 Primary staining (Hematoxylin Eosin and Histochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.2 Public Hospitals
7.5.3.3.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.3 Large Private Hospitals
7.5.3.3.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.4 Private
7.5.3.3.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Blood Banks
7.5.4.1 Blood Banks market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.2 SWA
7.5.4.2.1 SWA market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.3 Molecular Test
7.5.4.3.1 Molecular test market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Point of Care (PoC)
7.5.4.1 Point of Care (PoC) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.2 Clinics
7.5.4.2.1 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.3 Hospitals
7.5.4.3.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.4 Retail
7.5.4.4.1 Retail market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.5 Military premises
7.5.4.5.1 Military premises market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.6 Airports
7.5.4.6.1 Airports market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.7 Others
7.5.4.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5 Others
7.5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.2 NGS
7.5.5.2.1 NGS market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.3 Mass Spectrometry
7.5.5.3.1 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.4 Others
7.5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Region, 2018 - 2030 (Revenue, USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 Italy
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
8.6.1 Italy
8.6.1.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Italy In Vitro Diagnostics (IVD) Market - Competitive Analysis
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4. Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 F. Hoffmann-La Roche Ltd.
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Abbott
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 bioMerieux SA
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Danaher
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 QIAGEN
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 BD
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 Sysmex Corporation
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 DiaSorin S.p.A.
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 The Menarini Group
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 SENTINEL CH. SpA
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Quidel Corporation.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.101.4 Strategic initiatives

ページTOPに戻る

Table of Contents

Summary

Italy In Vitro Diagnostics Market Growth & Trends

The Italy in vitro diagnostics market size is expected to reach USD 3.74 billion by 2030, set to decline at a CAGR of -1.90% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is driven by the surge in demand for IVD products, owing to the increasing prevalence of target diseases and increasing awareness about early diagnostics of diseases among people. Moreover, the development of automated IVD systems for different healthcare service providers to provide accurate, precise, efficient, and error-free diagnosis is anticipated to boost the Italy IVD market in the coming years.

The Italy IVD market is likely to be supported by the increase in the development of POC tests that allow flexible, precise, easy-to-use, and speedy testing. For instance, in April 2021, DiaSorin launched the LIAISON Quick Detect COVID TrimericS Ab test and LIAISON IQ an immunodiagnostic POC reader. This test can detect specific IgG antibodies in 10 minutes. In addition, LINX DUO, developed by Menarini Diagnostics s.r.l, is a POC multi-assay automated analyzer for HbA1c and CRP testing capable of giving results in a span of a few minutes.

In addition, the companies operating in Italy IVD market are undertaking strategic initiatives such as partnerships and others to strengthen their product portfolio in point-of-care testing. For instance, in July 2020, A. Menarini Diagnostics and Skyla Corporation announced a distribution & supply agreement for LINX DUO multi-assay analyzer and LINX EVO clinical chemistry analyzer. With this partnership, Menarini is expected to strengthen its portfolio for POC diagnostics with state-of-the-art technology.

The increase in the aging population is anticipated to boost the uptake of IVD products thereby facilitating growth. The research found that the geriatric population is more susceptible to chronic diseases and according to the Instituto Superiore di Sanita, over 85% of people over 75 years suffer from chronic diseases. Some major diseases associated with aging are cardiovascular disorders, arthritis, diabetes, autoimmune disorders, and Alzheimer’s disease among others. The increasing risk of developing chronic disease is expected to further support the growth.

Furthermore, government bodies and key market players are taking favorable initiatives to facilitate healthcare services in the country. For instance, in June 2022, Sentinel diagnostics launched SENTiFIT 800 Analyzer, a high throughput and fully automated system for fecal immunochemical tests. Moreover, in April 2021, Lumos Diagnostics and DiaSorin entered into a strategic collaboration for the launch of the point-of-care portable immunoassay platform LIAISON IQ.

Italy In Vitro Diagnostics Market Report Highlights

• Reagents segment held the largest market share in 2022 owing to increasing demand for clinical tests for targeted diseases

• Based on the technology, the molecular diagnostics segment dominated Italy in vitro diagnostics (IVD) industry due to the continuous evolution in technology and market introduction of novel products

• The blood banks segment is anticipated to exhibit the fastest growth rate owing to the rising demand for automated instruments in blood banks and increasing blood transfusions

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Grand View Research社の臨床検査分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Grand View Research社はどのような調査会社ですか?

グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

イタリアの体外診断薬市場の規模、シェア、動向分析レポート：製品別（機器、試薬、サービス）、技術別、用途別（感染症、糖尿病、腫瘍/癌）、最終用途別、セグメント別予測、2023年～2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Grand View Research社の臨床検査分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Grand View Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?